CDKN2B-AS1 and colorectal carcinoma: In conclusion, we proved that ANRIL expression in clinical colorectal cancer was associated with overall survival, poor prognosis and chemoresistance, indicating that ANRIL may be a mediator for the functions of oncogene in CRC progression.